Clinical Studies Sponsored by Vaxart | 18 results

A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers

Name	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
‌ A Study to Evaluate VXA-CoV2-3.1 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection	NCT06672055	‌ Covid-19	October 8, 2024	2026	Interventional
‌ Safety Study of an Oral Vaccine to Prevent Avian Influenza	NCT01335347	‌ Bird flu Avian influenza	2011	2012	Interventional
‌ Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults	NCT04563702	‌ covid19	September 2020	October 2021	Interventional
‌ Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults	NCT03121339		March 31, 2017	April 3, 2018	Interventional
‌ A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers	NCT05213728		January 24, 2022	February 24, 2022	Interventional
‌ Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines	NCT03897309		March 20, 2019	April 1, 2021	Interventional
‌ Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines	NCT04875676		April 30, 2021	October 30, 2021	Interventional
‌ Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults	NCT02547792		October 20, 2015	November 21, 2016	Interventional
‌ Phase 1 Placebo-controlled, Randomized Trial of an Adenoviral-vector Based Norovirus Vaccine	NCT02868073		July 29, 2016	October 1, 2017	Interventional
‌ A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection	NCT03024177	Rhinovirus Upper respiratory tract infection			Interventional
‌ A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine	NCT02918006	Influenza	August 31, 2016	January 19, 2018	Interventional
‌ Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine	NCT04854746		April 26, 2021	January 4, 2022	Interventional
‌ A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients	NCT02724254	‌ Condyloma	2016	2018	Interventional
‌ Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers	NCT03125473		April 7, 2017	May 6, 2018	Interventional
‌ Norovirus Challenge Study	NCT05212168		January 28, 2022	June 2, 2024	Interventional
‌ A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers	NCT05626803		February 28, 2022	December 31, 2023	Interventional
‌ Safety Study of an Oral Vaccine to Prevent Seasonal Influenza	NCT01688297	Influenza	2012	2015	Interventional
‌ Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)	NCT02830932		June 22, 2016	September 20, 2017	Interventional